Clinical Trials Logo

Alzheimer Disease clinical trials

View clinical trials related to Alzheimer Disease.

Filter by:

NCT ID: NCT00743418 Recruiting - Dementia Clinical Trials

Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease

SenTra
Start date: June 2007
Phase: Phase 1/Phase 2
Study type: Interventional

The research is aimed at exploring the application of novel tracking technique for the study of spatial activity among dementia patients and its implication on their families. The study sample will be composed of three groups of volunteers, each including100 participants aged over 60 years. The first group will include MCI (Mild Cognitive Impairment) patients. The second group will include patients that suffer from mild dementia. The third group will include age matched healthy participants. The tracking equipment will be a GPS apparatus of 450 gms that will be carried by the participants for 24 hours along 2-4 weeks. The GPS data will be transferred via the cellular network to operator center at the Hebrew university at Jerusalem, and will be documented in assigned data files. This monitoring procedure will be held every year and along a period of five years. The impact of the patient behavior on the care giver will be studied by means of five interviews along the tracking period.

NCT ID: NCT00715858 Recruiting - Alzheimer's Disease Clinical Trials

A Pilot Study of Inflammatory Markers in Alzheimer's Disease

Start date: May 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the cerebrospinal fluid (CSF) of patients with Alzheimer's disease for biomarkers of inflammation and their response to the antibiotics doxycycline and rifampin. The results of this preliminary analysis will be used in defining the direction of further research.

NCT ID: NCT00703430 Recruiting - Alzheimer's Disease Clinical Trials

Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

Start date: March 2008
Phase: N/A
Study type: Interventional

Alzheimer's disease (AD), is associated with behavioral disturbances in approximately 50% of AD patients in Beijing. Agitation, and aggression specifically, is considered the most serious noncognitive symptom experienced in patients with dementia. Memantine is a recognized treatment for Alzheimer's disease either alone or in combination with cholinesterase inhibitors. Its efficacy in vascular dementia is also established. Family members continue to play a central role in home care for the demented elderly in China. This proposal is to conduct a study in Beijing, China to investigate the efficacy and safety of Memantine in the treatment of agitation and aggression in AD patients. In addition, this proposal aims to explore the impact of memantine on caregiver burden of AD patients in Chinese culture.

NCT ID: NCT00438724 Recruiting - Alzheimer Disease Clinical Trials

Couples Coping With Alzheimer's Disease

Start date: November 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of a new couples counseling intervention for people recently diagnosed with early Alzheimer's disease and their spouses. The study hypothesis is that counseling the couple shortly after the diagnosis, and while the functional impact of the illness is still relatively mild, will have a significant impact on their ability to provide support for each other.

NCT ID: NCT00409279 Recruiting - Alzheimer Disease Clinical Trials

An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease

Start date: September 2003
Phase: N/A
Study type: Interventional

The goal of this project is to test an intervention designed to reduce the incidence and magnitude of the negative effects, specifically stress, anxiety, and depression, frequently experienced by adult children who are caregivers of a parent with Alzheimer's disease (AD).

NCT ID: NCT00306124 Recruiting - Healthy Clinical Trials

Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment

Start date: January 2006
Phase: Phase 4
Study type: Interventional

This study aims to determine whether levodopa is effective in boosting learning and memory in healthy subjects and patients with dementia or Mild Cognitive Impairment. We also examine in healthy subjects using functional magnetic resonance imaging which brain regions mediate improved learning after levodopa administration.

NCT ID: NCT00232570 Recruiting - Alzheimer's Disease Clinical Trials

Quetiapine for the Treatment of Insomnia in Alzheimer's Disease

Start date: November 2005
Phase: N/A
Study type: Interventional

The primary hypothesis is that quetiapine will improve sleep in persons with Alzheimer's Disease (AD), with higher doses producing greater total sleep time and sleep efficiency.

NCT ID: NCT00192998 Recruiting - Alzheimer Disease Clinical Trials

The Serotonergic Transmitter System in Dementia and Affective Disorders

Start date: October 2003
Phase: N/A
Study type: Observational

The aim of this project is to examine the serotonergic transmitter system using functional imaging of the brain (positron emission tomography [PET]) to gain knowledge about early pathophysiological changes in Alzheimer's dementia and mood disorders.

NCT ID: NCT00192816 Recruiting - Clinical trials for Dementia Alzheimer Type

Pain Perception in Alzheimer's Disease

Start date: June 2005
Phase: N/A
Study type: Observational

The purpose of this study is to determine response to pain in Alzheimer's disease.We plan to study the effect of diffuse noxious inhibitory controls(counterirritation phenomenon)and the autonomic nervous system reaction(reflected by the heart rate) in Alzheimer's disease. The study's hypothesis is that pain perception and autonomic nervous system reaction are altered in Alzheimer's disease.

NCT ID: NCT00172900 Recruiting - Alzheimer's Disease Clinical Trials

MRS and DTI of White Matter in Alzheimer's Disease

Start date: June 2005
Phase: N/A
Study type: Observational

The white matter change of the Alzheimer's disease could be studied by diffusion tensor image and MR spectroscopy to see the microstructral and biochemical change.